Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Grundman

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
The Proceedings of the Nutrition Society|July 23, 2002
Antioxidant strategies for Alzheimer's diseaseMichael Grundman, Michael Grundman, Patrick Delaney
Archives of Neurology|January 12, 2005
Weight loss in the elderly may be a sign of impending dementiaMichael Grundman
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 22, 2008
A quarter century of advancing treatment for Alzheimer's disease with Leon J. ThalMichael Grundman
Journal of Alzheimer'S Disease : JAD|June 9, 2009
Anti-amyloid-beta immunotherapy in Alzheimer's disease: ACC-001 clinical trials are ongoingJ Michael Ryan, Michael Grundman
Journal of Alzheimer'S Disease : JAD|December 4, 2003
Hypothesis testing of a change point during cognitive decline among Alzheimer's disease patientsMing Ji, Chengjie Xiong, Michael Grundman
Neuro-Degenerative Diseases|August 16, 2006
A beta immunotherapy: Lessons learned for potential treatment of Alzheimer's diseaseDale B Schenk, Peter Seubert, Michael Grundman, et al.
Archives of Internal Medicine|May 14, 2003
NSAIDs and hypertensionPaul S Aisen, Kimberly Schafer, Michael Grundman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentJames E Galvin, Mary E Hamby, Jennifer Iaci, et al.
Neuro-Degenerative Diseases|March 7, 2008
Progress in the active immunotherapeutic approach to Alzheimer's disease: clinical investigations into AN1792-associated meningoencephalitisMichael Pride, Peter Seubert, Michael Grundman, et al.
Archives of Neurology|September 12, 2007
A neuropsychological test battery for use in Alzheimer disease clinical trialsJohn Harrison, Sonia L Minassian, Lisa Jenkins, et al.
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
The Proceedings of the Nutrition Society|July 23, 2002
Antioxidant strategies for Alzheimer's diseaseMichael Grundman, Michael Grundman, Patrick Delaney
Archives of Neurology|January 12, 2005
Weight loss in the elderly may be a sign of impending dementiaMichael Grundman
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 22, 2008
A quarter century of advancing treatment for Alzheimer's disease with Leon J. ThalMichael Grundman
Journal of Alzheimer'S Disease : JAD|June 9, 2009
Anti-amyloid-beta immunotherapy in Alzheimer's disease: ACC-001 clinical trials are ongoingJ Michael Ryan, Michael Grundman
Journal of Alzheimer'S Disease : JAD|December 4, 2003
Hypothesis testing of a change point during cognitive decline among Alzheimer's disease patientsMing Ji, Chengjie Xiong, Michael Grundman
Neuro-Degenerative Diseases|August 16, 2006
A beta immunotherapy: Lessons learned for potential treatment of Alzheimer's diseaseDale B Schenk, Peter Seubert, Michael Grundman, et al.
Archives of Internal Medicine|May 14, 2003
NSAIDs and hypertensionPaul S Aisen, Kimberly Schafer, Michael Grundman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentJames E Galvin, Mary E Hamby, Jennifer Iaci, et al.
Neuro-Degenerative Diseases|March 7, 2008
Progress in the active immunotherapeutic approach to Alzheimer's disease: clinical investigations into AN1792-associated meningoencephalitisMichael Pride, Peter Seubert, Michael Grundman, et al.
Archives of Neurology|September 12, 2007
A neuropsychological test battery for use in Alzheimer disease clinical trialsJohn Harrison, Sonia L Minassian, Lisa Jenkins, et al.
Pageof 8